{"name":"Antares Pharma Inc.","slug":"antares-pharma-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimgJBVV95cUxPa2NIQ3N6S3EzX0NyS200bzhURi1KUnNEc01tRzR4MGNpQU1IdjBlZDQ3NWx2NmtlcXM0NWpYT3pfWHhlMGFqTFlxNzRYUGVYREo1MmI5NGlLUHNoUXk2MThpcllLSHRYZWgyY2dXTF9JNWplbmFXZXZjNGNCUGlDbmRwaThQWFQtd2cwRG5wV3h2eW9lX1hBYVVUUnBrWlZVNTVqd0ZnMzhCSE12MWZVdHZfTjdSQnN0cWtGdzJMbGhldWtZVHBJN2I2OHV5ck5mVVc0a2NxY1lnZmYtbVdUQ1NrVEtDeHd3U0tZUVhtWjdvZnFFLU9GVUZrOVU2VGZKQVozdnI4eEE1bFhxMzlQckhLRWVaV0QydUE?oc=5","date":"2025-06-10","type":"pipeline","source":"businesswire.com","summary":"Antares Therapeutics Launches with $177 Million to Develop First-in-Class Precision Medicines for Cancer and Other Serious Diseases - businesswire.com","headline":"Antares Therapeutics Launches with $177 Million to Develop First-in-Class Precision Medicines for Cancer and Other Serio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPc2VZanZpalc4eWYySVZkNzRYR0I3Q3RDUEtvZ2p2S0xuYkVRS0xtMDFSMThiUDV0U3lNQllwWjZFeFNWMU5vMXpMTTRnN1lYck54enZaT2JpVEdRNFpTd2ZGQTNISlhMSHFYTmQyOS13RTFCaXU1Z25WRl9NVTU5ZFM3VUc5R1FfM1FxV19mbnVNbW92Skhjd0pPWm43U0JfOGcw?oc=5","date":"2022-05-24","type":"pipeline","source":"PR Newswire","summary":"Halozyme Completes Antares Pharma Acquisition - PR Newswire","headline":"Halozyme Completes Antares Pharma Acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxONjF6OHdGcUpMcERRZmFBSEpld19HOVNadDRiNW80LUZuR2lITEhEQzNvRzY3a00wOEo3VzNHa0NjcXhlNVB1M2M3LXpxNG1DYnFua0ZuejFlWDQ1RjBrdEhYcTJQNjJWRENCbmF6bzI2RGQ2NEV4YzRUanBKbW0tdGczNHVsZjJsYWk0Y0FRc9IBjwFBVV95cUxONjF6OHdGcUpMcERRZmFBSEpld19HOVNadDRiNW80LUZuR2lITEhEQzNvRzY3a00wOEo3VzNHa0NjcXhlNVB1M2M3LXpxNG1DYnFua0ZuejFlWDQ1RjBrdEhYcTJQNjJWRENCbmF6bzI2RGQ2NEV4YzRUanBKbW0tdGczNHVsZjJsYWk0Y0FRcw?oc=5","date":"2022-05-05","type":"pipeline","source":"Law Street Media","summary":"Antares Pharma Sued for Alleged SEC Violations - Law Street Media","headline":"Antares Pharma Sued for Alleged SEC Violations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNX2xqWmxNSU5qVl9ROTlzdkFfT2pRSUZOaVN4blp6cWZjWUQ0VmtqQ1BGOWJFem5PQi1oMVN4YTI2bHBoTzhoVUxmNm5NYjB5LTJLZkxsX3d4a0h0VkFVQk85SUo5VGJUVnhDak9wR1VwanpUY19nNHFVNlZDSUh2d3NaVHBhUQ?oc=5","date":"2022-04-14","type":"deal","source":"Pharmaceutical Technology","summary":"Halozyme signs agreement to acquire Antares Pharma for $960m - Pharmaceutical Technology","headline":"Halozyme signs agreement to acquire Antares Pharma for $960m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNeW84a1M4N2Y0c3ZUWGhDRTZGNEtlNEhHeHBLSHZrOGxDRkpkMWkzUTBBOWN3X3M0NjVDMEZMbVNRODAxVktUZ3BJUGJEN3ZyaWI4d244a3E0X1RmaU83ZkZZLTAxOGhtMXRUckdFQ01ZS1NyRzVJX3BiZ1VaeWNxM0hQdXZGOFVSRkxZWjFFQTF1SklmM3BYZQ?oc=5","date":"2022-04-14","type":"deal","source":"Contract Pharma","summary":"Halozyme to Acquire Antares Pharma in $960M Deal - Contract Pharma","headline":"Halozyme to Acquire Antares Pharma in $960M Deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPYVRpUFJwVFBYY09tV3UxQml4LVc5U0FTZ0kyN19PMzZ6ZWdrVFNZb1dZREY3SjNpX082a09ySDg2Sm9pN1BfSC15Ni1iNHJtTFJEMUp5UlRnU2FJTmw4NGpweHBuajc3dzdISm96YlVJQlhOb09BZVlhaE5Ic1M0eDBGM0pjV083enFjN29hMXBpNWVmMkw0MDA5UjV1MDRkX0F4N2tGVS1GOVNHSktLeQ?oc=5","date":"2022-04-13","type":"deal","source":"drugdeliverybusiness.com","summary":"Halozyme acquires Antares Pharma for $960M to create drug delivery company - drugdeliverybusiness.com","headline":"Halozyme acquires Antares Pharma for $960M to create drug delivery company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE5qUW5URkpRNENzTUZUeHhDdzNnQkFFalg2VlN3TlpoNHlDVENfNC1CNjc5LUxwNm5zQnE0bzI1SktpMWo2VjE5c25QMlhIYk4xaEs3NGlkQU9rSXZuN0twZFBEdnhzM3lfb1BST2hzV3p4WU5iSmxIZlI4UDU?oc=5","date":"2022-04-13","type":"deal","source":"NJBIZ","summary":"Halozyme acquires Ewing-based Antares Pharma for $960M - NJBIZ","headline":"Halozyme acquires Ewing-based Antares Pharma for $960M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQOFlUTU1LSWFYUW12UFNodTJtbkVfTXJlR3RHcHhYT0xKQTNneFBIS3IxdHJTeXJoUHpMbkRtcjJTT09zTVBGRGg2VmpkXzZ3eURvZkVuU1pfMG94VFJNMjN1MVBPTVUyV2JDTkp6U2tXWWJkZ1pRa3BkMFdWUVJyQzZ0NGdaN0E0?oc=5","date":"2022-04-13","type":"deal","source":"Barron's","summary":"Antares Pharma Stock Soars After $960 Million Halozyme Buyout - Barron's","headline":"Antares Pharma Stock Soars After $960 Million Halozyme Buyout - Barron's","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxOVlF0MlpVLVlhUk82eFU2RVRXbVBST2JReHNWSktuTE04Z0JBQzZ1ZXVsWHZFV2RHMGQyd254cEVMRGlURnZXa3BwNDlCQVV3bl9VS0NqQms1Tk91RFVFU1JaUXVpWkxnWUpsbGpMbllEdUhlamw1QzA0S1MySTAtdUgwX042VzRWVjEzMU1IV1RhOE9Kd1NhOWVkNTlWNW40ZmpOemlSVl9FUXp0RUY2bWc2SFBoeVEtWENwQUN2U09Ud3NVYXdseUc4eFR3cjVvdjZLa3hreWdaTzJ3eEE?oc=5","date":"2022-04-13","type":"deal","source":"PR Newswire","summary":"Halozyme to Acquire Antares Pharma to Create a Specialty Product and Drug Delivery Leader - PR Newswire","headline":"Halozyme to Acquire Antares Pharma to Create a Specialty Product and Drug Delivery Leader","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQOU9scVJCa1hMQllJYXRlcFJ0Vnp0RTJBa1liTlJkVDVDYVRURW1Ga2phY2N6dmRqYlIyUG5leTQ4RWZKcGc1SUZDaWRjakNBZDZIZk5Vd043ZDl2SWtMeGxJQWM3X19KclN2ajBRMjRjakowTjNsUkZreFN1S0dPTk1zcDZGOEFJR2xtNEJpVEtkbjJ3SkZHbQ?oc=5","date":"2022-03-03","type":"pipeline","source":"SEC.gov","summary":"Document - SEC.gov","headline":"Document","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNeW9jd0hVekxBRzBISWZ0VEpSRERydVd0ZlJER2R1QkZYc2tWc2ZJZ1dWbnBIZVJIcS15T1BYbVdFSVZBcHVSTDFESTVka3VDYS1aTHM0OXdZSi1CZmRSSzVOMm8zUmctdzJKOVNMbmhGMEppZXZNRmVfLThibmZQSUk1ZDFHQmlYLXdkaFNCS3czSnBsZnhzVXlndUxSbjFTalQtSThRN182V1Q1eFJBT1BqUlpmb2VzQ1BYbHM3ZlV3UVRW?oc=5","date":"2022-02-07","type":"pipeline","source":"Fierce Pharma","summary":"Antares Pharma develops novel auto-injector devices for innovative combination products - Fierce Pharma","headline":"Antares Pharma develops novel auto-injector devices for innovative combination products","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxQcW9haHhHa1VJY09UWklnU0dETURHWUtkNVVaVUNlbDZTc001ajZueVdOX3JDZXYyLVdzUHk0Ykw2MGw3bzk3cTBDY092WHhrcGV2OWplQkZwNVFwRmpfM0hoNEFtbmlTZklFcHU5bDdMa1pMS3hvMkkwbENYV2JYYjI2OXpCSWJnQk90RU1NM0hFVlg2OVNVeGlKUWtNYkp2Mkt4b1BQYnYwb1htRG5idmtYS0Mwb2RndF9vSmFCcjhfNUVQQU5Ud0ZJcjQwUmsxRExxdTlHYWR0cHVaXzBqTkxyQVNZTWVmVmVTOV92dnQ1SzVGWmRyMVZEVnJIaFpOSEZ6bmd4Qm5GTmx2VjNPa200OC1abnhGVzhPRWhR?oc=5","date":"2021-12-15","type":"pipeline","source":"GlobeNewswire","summary":"Assertio Holdings, Inc. Announces the Acquisition of - GlobeNewswire","headline":"Assertio Holdings, Inc. Announces the Acquisition of","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}